Compare PLRX & ZKH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PLRX | ZKH |
|---|---|---|
| Founded | 2015 | 1998 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 93.3M | 587.4M |
| IPO Year | 2020 | 2023 |
| Metric | PLRX | ZKH |
|---|---|---|
| Price | $1.22 | $3.64 |
| Analyst Decision | Hold | |
| Analyst Count | 11 | 0 |
| Target Price | ★ $3.79 | N/A |
| AVG Volume (30 Days) | ★ 1.9M | 245.2K |
| Earning Date | 11-06-2025 | 11-20-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $1,236,195,501.00 |
| Revenue This Year | N/A | $2.58 |
| Revenue Next Year | N/A | $10.62 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.10 | $2.50 |
| 52 Week High | $14.26 | $3.90 |
| Indicator | PLRX | ZKH |
|---|---|---|
| Relative Strength Index (RSI) | 36.77 | 73.83 |
| Support Level | $1.20 | $3.16 |
| Resistance Level | $1.27 | $3.31 |
| Average True Range (ATR) | 0.07 | 0.15 |
| MACD | 0.00 | 0.03 |
| Stochastic Oscillator | 20.00 | 67.50 |
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.
ZKH Group Ltd engages in providing MRO procurement service platform in China. It provides one-stop MRO procurement and management services for its customers, and offers digital and fulfillment solutions for participants along the industry value chain. It offers a broad range of MRO product offerings covering all MRO product lines on its platform, including spare parts, chemicals, manufacturing parts, general consumables, and office supplies. All of the Group's revenues are derived from the PRC.